Gyre Therapeutics Inc. (GYRE) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO, CA 92130 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments, including: | 33,500 | 21,700 | 46,900 | 81,900 | 76,900 | 120,100 | |||
| Cash and cash equivalents | 33,509 | 21,666 | 44,347 | 30,360 | 15,369 | 31,213 | |||
| Short-term investments | 2,504 | 48,994 | 61,496 | 88,914 | |||||
| Other undisclosed cash, cash equivalents, and short-term investments | (9) | 34 | 49 | 2,546 | 35 | (27) | |||
| Restricted cash and investments | 50 | ||||||||
| Receivables | 15,552 | 1,818 | 3,313 | 15,000 | |||||
| Inventory, net of allowances, customer advances and progress billings | 4,281 | ||||||||
| Inventory | 4,281 | ||||||||
| Other current assets | 1,045 | ||||||||
| Other undisclosed current assets | 2,843 | 6,506 | 2,758 | 4,297 | 4,166 | 3,841 | |||
| Total current assets: | 57,221 | 28,206 | 51,476 | 89,510 | 96,066 | 123,991 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 489 | 66 | 2,744 | 1,832 | 1,927 | ✕ | |||
| Property, plant and equipment | 23,288 | 4 | 970 | 433 | 304 | 386 | |||
| Long-term investments and receivables | 2,543 | ||||||||
| Long-term investments | 2,543 | ||||||||
| Intangible assets, net (including goodwill) | 205 | ||||||||
| Intangible assets, net (excluding goodwill) | 205 | ||||||||
| Deferred income tax assets | 4,695 | ✕ | |||||||
| Other noncurrent assets | 995 | 168 | 472 | 528 | 257 | 543 | |||
| Other undisclosed noncurrent assets | 29,646 | ||||||||
| Total noncurrent assets: | 59,318 | 238 | 4,186 | 5,336 | 2,488 | 929 | |||
| TOTAL ASSETS: | 116,539 | 28,444 | 55,662 | 94,846 | 98,554 | 124,920 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 11,935 | 11,786 | 11,958 | 15,150 | 13,416 | 4,786 | |||
| Employee-related liabilities | ✕ | ✕ | ✕ | 1,467 | 2,476 | 2,106 | 1,495 | ||
| Accounts payable | 355 | 194 | 6,419 | 5,931 | 4,279 | 1,248 | |||
| Accrued liabilities | 6,614 | 11,592 | 4,072 | 6,743 | 7,031 | 2,043 | |||
| Other undisclosed accounts payable and accrued liabilities | 4,966 | ||||||||
| Deferred revenue | 39 | 230 | 1,983 | 15,000 | ✕ | ||||
| Debt | 483 | ||||||||
| Deferred rent credit | 15 | ||||||||
| Other liabilities | 1,369 | ||||||||
| Other undisclosed current liabilities | 6,704 | 5,038 | 1,977 | 663 | |||||
| Total current liabilities: | 20,047 | 16,824 | 14,165 | 17,796 | 28,899 | 4,801 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation: | 408 | 981 | 1,319 | ||||||
| Liabilities, other than long-term debt | 13,296 | 174 | |||||||
| Deferred revenue | 213 | ✕ | |||||||
| Deferred rent credit | 174 | ||||||||
| Other liabilities | 49 | ||||||||
| Operating lease, liability | 199 | 408 | 981 | 1,319 | ✕ | ||||
| Derivative instruments and hedges, liabilities | 12,835 | ||||||||
| Other undisclosed noncurrent liabilities | 4,722 | (408) | (981) | ||||||
| Total noncurrent liabilities: | 18,018 | 408 | 981 | 1,319 | 174 | ||||
| Total liabilities: | 38,065 | 16,824 | 14,573 | 18,777 | 30,218 | 4,975 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | (15,828) | (21,689) | 41,089 | 76,069 | 68,336 | 119,945 | |||
| Common stock | 77 | 37 | 31 | 22 | 12 | 12 | |||
| Additional paid in capital | 68,179 | 389,210 | 443,752 | 390,803 | 326,810 | 323,279 | |||
| Accumulated other comprehensive income (loss) | (1,644) | 5 | 34 | (4) | |||||
| Accumulated deficit | (85,538) | (410,936) | (402,694) | (314,761) | (258,520) | (203,342) | |||
| Other undisclosed equity, attributable to parent | 3,098 | ||||||||
| Equity, attributable to noncontrolling interest | 29,777 | ||||||||
| Other undisclosed equity | 33,309 | ||||||||
| Total equity: | 13,949 | 11,620 | 41,089 | 76,069 | 68,336 | 119,945 | |||
| Other undisclosed liabilities and equity | 64,525 | ||||||||
| TOTAL LIABILITIES AND EQUITY: | 116,539 | 28,444 | 55,662 | 94,846 | 98,554 | 124,920 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 113,450 | 7,338 | 20,948 | 6 | ||||
| Cost of revenue (Cost of Goods and Services Sold) | (4,636) | |||||||
| Gross profit: | 108,814 | 7,338 | 20,948 | 6 | ||||
| Operating expenses | (176,044) | (9,405) | (95,232) | (78,318) | (57,277) | (33,828) | ||
| Other undisclosed operating income | 794 | |||||||
| Operating loss: | (67,230) | (8,611) | (87,894) | (57,370) | (57,277) | (33,822) | ||
| Nonoperating income (expense) | (1,518) | (87) | 659 | (39) | 1,654 | |||
| Other nonoperating income (expense) | (1,518) | (87) | 659 | (39) | 1,650 | |||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | ||||||||
| Loss from continuing operations before equity method investments, income taxes: | (68,748) | (8,611) | (87,981) | (56,711) | (57,316) | (32,168) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | (8,217) | 717 | ||||||
| Loss from continuing operations before income taxes: | (76,965) | (7,894) | (87,981) | (56,711) | (57,316) | (32,168) | ||
| Income tax expense | (8,515) | (348) | ||||||
| Loss from continuing operations: | (85,480) | (8,242) | (87,981) | (56,711) | (57,316) | (32,168) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (87,981) | (56,711) | (57,316) | (32,168) | |
| Other undisclosed net income | 48 | 470 | 2,138 | 2,113 | ||||
| Net loss: | (85,480) | (8,242) | (87,933) | (56,241) | (55,178) | (30,055) | ||
| Net loss attributable to noncontrolling interest | (7,453) | |||||||
| Other undisclosed net income attributable to parent | 7,453 | |||||||
| Net loss attributable to parent: | (85,480) | (8,242) | (87,933) | (56,241) | (55,178) | (30,055) | ||
| Other undisclosed net loss available to common stockholders, basic | (7,453) | |||||||
| Net loss available to common stockholders, basic: | (92,933) | (8,242) | (87,933) | (56,241) | (55,178) | (30,055) | ||
| Other undisclosed net loss available to common stockholders, diluted | ||||||||
| Net loss available to common stockholders, diluted: | (92,933) | (8,242) | (87,933) | (56,241) | (55,178) | (30,055) | ||
Comprehensive Income ($ in thousands)
| 9/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (85,480) | (8,242) | (87,933) | (56,241) | (55,178) | (30,055) | ||
| Other undisclosed comprehensive loss | (1,484) | |||||||
| Comprehensive loss: | (86,964) | (8,242) | (87,933) | (56,241) | (55,178) | (30,055) | ||
| Comprehensive loss, net of tax, attributable to noncontrolling interest | (6,806) | |||||||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (5) | (29) | 38 | (4) | ||||
| Comprehensive loss, net of tax, attributable to parent: | (93,770) | (8,242) | (87,938) | (56,270) | (55,140) | (30,059) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.